Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Iterum Therapeutics plc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 20 | 24 | +4 |
| Shares | 1.12M | 2.39M | +1.27M (+113.5%) |
| Value | $1.38M | $2.38M | +$1.00M (+72.7%) |
New holders (6)
Institutions that held Iterum Therapeutics plc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 456,861 | $454.6K | 0.00% |
| Sabby Management, LLC | 430,761 | $428.6K | 3.30% |
| Jane Street Group, LLC | 92,943 | $92.5K | 0.00% |
| Captrust Financial Advisors | 11,500 | $11.4K | 0.00% |
| Raymond James Financial Inc | 4,513 | $4.49K | 0.00% |
| Royal Bank of Canada | 5 | $0 | 0.00% |
Sold out (2)
Institutions that held Iterum Therapeutics plc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lee Financial Co | 16,000 | $19.7K |
| Two Sigma Securities, LLC | 10,709 | $13.2K |